PARTI Company Overview We are a late-stage clinical specialty pharmaceutical company focused on the development and commercialization of therapeutic products that treat rare and orphan diseases for which there are currently either no approved or very limited treatments or cures. Our lead product, QRX003, is under clinical development as a potential treatment for Netherton Syndrome (NS), a rare hereditary genetic disease. QRX003 is entering pivotal registrational clinical testing under an open In...
Q2 FY2026 — expected 2026-08-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001104659-26-035251 | EDGAR | 81K words |
| 2025-03-13 | 2024-12-31 | 0001410578-25-000336 | EDGAR | — |
| 2024-03-14 | 2023-12-31 | 0001410578-24-000198 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001410578-23-000267 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001104659-25-107785 | EDGAR | 20K words |
| 2025-08-07 | 2025-06-30 | 0001410578-25-001613 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001410578-25-001226 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001410578-24-001804 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001410578-24-001216 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001410578-24-000701 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001410578-23-002320 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0001410578-23-001531 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001410578-23-000940 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001104659-26-034951 | EDGAR | 3K words |
| 2026-03-11 | 0001104659-26-026410 | EDGAR | — |
| 2026-01-20 | 0001104659-26-005127 | EDGAR | — |
| 2025-11-17 | 0001104659-25-113237 | EDGAR | — |
| 2025-11-12 | 0001104659-25-109802 | EDGAR | — |
| 2025-11-06 | 0001104659-25-107747 | EDGAR | — |
| 2025-10-21 | 0001104659-25-101269 | EDGAR | — |
| 2025-10-15 | 0001104659-25-099735 | EDGAR | — |
| 2025-08-27 | 0001104659-25-083248 | EDGAR | — |
| 2025-08-21 | 0001104659-25-081480 | EDGAR | — |
264 total filings indexed. 241 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001671502 |
| Ticker | QNRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L3 |
| Website | https://www.quoinpharma.com |
| Listed | 2021-10-28 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report